Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiguo Liu

Showing results (451-460 of 457) with videos related to

Pageof 46
Sort By:
You have reached the last page of results.This site can display upto 457 results.
Plos Medicine|August 1, 2025
Deep brain stimulation surgical timing, outcomes, and prognostic factors in patients with Parkinson's disease: A Chinese retrospective multicenter cohort studyShu Wang, Wei Hu, Yuan Gao, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2022
The Chinese Parkinson's Disease Registry (CPDR): Study Design and Baseline Patient CharacteristicsXiaoxia Zhou, Zhenhua Liu, Xiaoting Zhou, et al.
NPJ Parkinson'S Disease|March 28, 2026
The genetic spectrum of LRRK2 variants in Parkinson's disease: findings from a large Chinese cohortJuan Wan, Hongxu Pan, Dong Chang, et al.
Brain : a Journal of Neurology|July 3, 2020
The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland populationYuwen Zhao, Lixia Qin, Hongxu Pan, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
NPJ Parkinson'S Disease|February 9, 2023
Genome-wide association study using whole-genome sequencing identifies risk loci for Parkinson's disease in Chinese populationHongxu Pan, Zhenhua Liu, Jinghong Ma, et al.
Pageof 46

Showing results (451-460 of 457) with videos related to

Sort By:
Pageof 46
You have reached the last page of results.This site can display upto 457 results.
Plos Medicine|August 1, 2025
Deep brain stimulation surgical timing, outcomes, and prognostic factors in patients with Parkinson's disease: A Chinese retrospective multicenter cohort studyShu Wang, Wei Hu, Yuan Gao, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2022
The Chinese Parkinson's Disease Registry (CPDR): Study Design and Baseline Patient CharacteristicsXiaoxia Zhou, Zhenhua Liu, Xiaoting Zhou, et al.
NPJ Parkinson'S Disease|March 28, 2026
The genetic spectrum of LRRK2 variants in Parkinson's disease: findings from a large Chinese cohortJuan Wan, Hongxu Pan, Dong Chang, et al.
Brain : a Journal of Neurology|July 3, 2020
The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland populationYuwen Zhao, Lixia Qin, Hongxu Pan, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
NPJ Parkinson'S Disease|February 9, 2023
Genome-wide association study using whole-genome sequencing identifies risk loci for Parkinson's disease in Chinese populationHongxu Pan, Zhenhua Liu, Jinghong Ma, et al.
Pageof 46